← All Cg Oncology, INC filings

Cg Oncology, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
CGON
Cg Oncology, INC
DEF: CG Oncology 2026 Annual Meeting Proxy Statement
CG Oncology, Inc. has filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held on June 4, 2026.
NASDAQ
CGON
Cg Oncology, INC
DEFA14A: CG Oncology Files Definitive Proxy Statement for Upcoming Shareholder Meeting
CG Oncology has filed its definitive proxy statement, signaling preparations for an upcoming shareholder meeting.
NASDAQ
CGON
Cg Oncology, INC
DEF: CG Oncology Sets Date for 2025 Annual Stockholders Meeting, Outlines Key Proposals
CG Oncology announces its 2025 Annual Meeting of Stockholders to be held virtually on June 5, 2025, featuring proposals for director elections and ratification of the company's independent auditor.